Business
Bristol Myers Squibb to Build a $2.3 Billion Drug-Manufacturing Campus in Houston
The multi-modality site — making small molecules, biologics and antibody-drug conjugates — is part of BMS’s $40 billion U.S. push amid tariffs and reshoring.